177 related articles for article (PubMed ID: 35793869)
1. Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature.
Wong-Rolle A; Dong Q; Zhu Y; Divakar P; Hor JL; Kedei N; Wong M; Tillo D; Conner EA; Rajan A; Schrump DS; Jin C; Germain RN; Zhao C
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793869
[TBL] [Abstract][Full Text] [Related]
2. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients.
Zhang B; Liu J; Li H; Huang B; Zhang B; Song B; Bao C; Liu Y; Wang Z
Front Pharmacol; 2023; 14():1244752. PubMed ID: 37745080
[No Abstract] [Full Text] [Related]
3. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer.
Sheng D; Yue K; Li H; Zhao L; Zhao G; Jin C; Zhang L
Microbiol Spectr; 2023 Mar; 11(2):e0354922. PubMed ID: 36975828
[TBL] [Abstract][Full Text] [Related]
4. Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers.
Liu Z; Hong LL; Ling ZQ
Cancer Med; 2023 Aug; 12(16):16756-16773. PubMed ID: 37377377
[TBL] [Abstract][Full Text] [Related]
5. Intratumor microbiome derived glycolysis-lactate signatures depicts immune heterogeneity in lung adenocarcinoma by integration of microbiomic, transcriptomic, proteomic and single-cell data.
Deng X; Chen X; Luo Y; Que J; Chen L
Front Microbiol; 2023; 14():1202454. PubMed ID: 37664112
[TBL] [Abstract][Full Text] [Related]
6. Intratumor microbiome-derived butyrate promotes lung cancer metastasis.
Ma Y; Chen H; Li H; Zheng M; Zuo X; Wang W; Wang S; Lu Y; Wang J; Li Y; Wang J; Qiu M
Cell Rep Med; 2024 Apr; 5(4):101488. PubMed ID: 38565146
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer.
Zhao W; Zhu B; Hutchinson A; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Wang D; Shi J; Landi MT
J Natl Cancer Inst; 2022 Feb; 114(2):280-289. PubMed ID: 34402912
[TBL] [Abstract][Full Text] [Related]
9. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer.
Chen F; Yang J; Guo Y; Su D; Sheng Y; Wu Y
Front Immunol; 2023; 14():1140995. PubMed ID: 36999009
[TBL] [Abstract][Full Text] [Related]
10. Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies.
Larroquette M; Guegan JP; Besse B; Cousin S; Brunet M; Le Moulec S; Le Loarer F; Rey C; Soria JC; Barlesi F; Bessede A; Scoazec JY; Soubeyran I; Italiano A
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618288
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.
Liu Z; Zhang X; Zhang H; Zhang H; Yi Z; Zhang Q; Liu Q; Liu X
Microbiol Spectr; 2023 Feb; 11(2):e0503822. PubMed ID: 36786568
[TBL] [Abstract][Full Text] [Related]
12. Intratumor microbiota: a novel tumor component.
Gong Y; Huang X; Wang M; Liang X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6675-6691. PubMed ID: 36639531
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
Francisco-Cruz A; Rocha P; Reuben A; Krishnan SN; Das P; Chen R; Quek K; Li J; Parra ER; Solis LM; Barua S; Jiang M; Lazcano R; Chow CW; Behrens C; Gumb C; Little L; Fukuoka J; Kalhor N; Weissferdt A; Kadara H; Heymach JV; Swisher S; Sepesi B; Rao A; Moran C; Zhang J; Lee JJ; Fujimoto J; Futreal PA; Wistuba II; Peterson CB; Zhang J
Mod Pathol; 2023 Jan; 36(1):100028. PubMed ID: 36788067
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
[TBL] [Abstract][Full Text] [Related]
15. Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma.
Song Y; Xiang Z; Lu Z; Su R; Shu W; Sui M; Wei X; Xu X
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11319-11332. PubMed ID: 37380815
[TBL] [Abstract][Full Text] [Related]
16. Untangling the web of intratumor microbiota in lung cancer.
Liu W; Xu J; Pi Z; Chen Y; Jiang G; Wan Y; Mao W
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189025. PubMed ID: 37980944
[TBL] [Abstract][Full Text] [Related]
17. Spatial maps of hepatocellular carcinoma transcriptomes reveal spatial expression patterns in tumor immune microenvironment.
Wang YF; Yuan SX; Jiang H; Li ZX; Yin HZ; Tan J; Dai ZH; Ge CM; Sun SH; Yang F
Theranostics; 2022; 12(9):4163-4180. PubMed ID: 35673582
[No Abstract] [Full Text] [Related]
18. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic and genomic profiling of multiple primary colorectal cancers reveals intratumor heterogeneity and a distinct immune microenvironment.
Li Y; Li C; Wang Q; Ye YJ; Jiang KW
Int Immunopharmacol; 2024 Jan; 126():111276. PubMed ID: 38016348
[TBL] [Abstract][Full Text] [Related]
20. Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.
Zhou X; You L; Xin Z; Su H; Zhou J; Ma Y
J Transl Med; 2023 Nov; 21(1):800. PubMed ID: 37950236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
